Lyra Therapeutics
LYRA
LYRA
36 hedge funds and large institutions have $109M invested in Lyra Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.44% more ownership
Funds ownership: 0.77% → 1.21% (+0.44%)
Holders
36
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$33.5M | |
| 2 | +$13.4M | |
| 3 | +$11.6M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$10M |
| 5 |
VA
VR Adviser
New York
|
+$5.22M |
Top Sellers
| 1 | -$424K | |
| 2 | -$241K | |
| 3 | -$136K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$56.4K |
| 5 |
Morgan Stanley
New York
|
-$33K |